Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non–Small Cell Lung Cancer

Published:2021-04-14 Issue:12 Volume:81 Page:3295-3308
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Li Rui,Salehi-Rad Ramin,Crosson William,Momcilovic Milica,Lim Raymond J.^ORCID,Ong Stephanie L.,Huang Zi Ling,Zhang Tianhao^ORCID,Abascal Jensen,Dumitras Camelia,Jing Zhe,Park Stacy J.,Krysan Kostyantyn^ORCID,Shackelford David B.,Tran Linh M.^ORCID,Liu Bin,Dubinett Steven M.

Funder

National Cancer Institute

National Heart Lung and Blood Institute

Department of Veteran AffairsNIHNCATSNCATS

NIH

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non–Small Cell Lung Cancer. An Official American Thoracic Society Research Statement;American Journal of Respiratory and Critical Care Medicine;2024-09-01

2. Rab3B enhances the stabilization of DDX6 to promote lung adenocarcinoma aggressiveness;Molecular Medicine;2024-06-04

3. Glucocorticoids in lung cancer: Navigating the balance between immunosuppression and therapeutic efficacy;Heliyon;2024-06

4. Immunosuppressive regulatory cells in cancer immunotherapy: restrain or modulate?;Human Cell;2024-05-30

5. Immune cells mediated the causal relationship between the gut microbiota and lung cancer: a Mendelian randomization study;Frontiers in Microbiology;2024-05-03